PMDA drug package insert
ミケランLA点眼液1％
PMDA Prescription drug · 大塚製薬株式会社 · package insert Mar 30, 2022
Key facts
| Brand names | ミケランLA点眼液1％, ミケランLA点眼液2％ |
|---|---|
| Nonproprietary names | カルテオロール塩酸塩 |
| Companies | 製造販売元／大塚製薬株式会社, 提携／千寿製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 緑内障・高眼圧症治療剤 |
| Therapeutic category codes | 871319 |
| YJ codes | 1319701Q3024, 1319701Q4020 |
| Approval numbers | 21900AMZ00063, 21900AMZ00064 |
| Package insert edition | 第1版 |
| Package insert date | Mar 30, 2022 |
| PMDA document key | 180078_1319701Q3024_1 |
| PMDA company code | 180078 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: